Interleukin-6 level in patients with colorectal cancer

Cancer Lett. 2006 Nov 28;244(1):76-8. doi: 10.1016/j.canlet.2005.12.003. Epub 2006 Jan 25.

Abstract

Interleukin-6 (IL-6) contributes to a multitude of physiological and pathophysiological processes. We sought to determine the level of the IL-6 in serum and tumoral tissue of patients with staging of the tumor and whether serum IL-6 level in patients with colorectal cancer correlate with tumoral tissue level of it. Serum and tumoral tissue specimen (stored at -80 degrees C until the biochemical determination) from colorectal cancer (n=50) were examined for IL-6.we determined the IL-6 Level in serum and tumoral tissue supernatant with Instant ELISA kit. A significant association between serum IL-6 level and staging of the tumor (P<0.001), tumoral tissue IL-6 level (r=0.95, P<0.001) in the patients was founded. IL-6 amount of the serum and tumoral tissue in the patients with colorectal cancer correlate significantly with the staging of the tumor and with each other.

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / metabolism
  • Colorectal Neoplasms / metabolism*
  • Colorectal Neoplasms / pathology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interleukin-6 / metabolism*
  • Male
  • Middle Aged
  • Neoplasm Staging

Substances

  • Biomarkers, Tumor
  • Interleukin-6